Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER IMMUNOTHERAPY

Modelling treatment-response rates

Nature Biomedical Engineering volume 5, pages 295–296 (2021)Cite this article

Subjects

The time course of tumour responses to immunotherapies can be mathematically predicted on the basis of tumour-growth rates, the rates of immune activation and of tumour–immune-cell interactions, and the efficacy of immune-mediated tumour killing.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: A general mathematical model can discriminate patients who respond to immunotherapies from those who do not.

References

  1. Ngwa, W. et al. Nat. Rev. Cancer 18, 313–322 (2018).

    Article  CAS  Google Scholar 

  2. Postow, M. A. et al. N. Engl. J. Med. 372, 2006–2017 (2015).

    Article  Google Scholar 

  3. Boland, G. M. & Flaherty, K. T. Nat. Cancer 1, 160–162 (2020).

    Article  Google Scholar 

  4. Schwartz, L. H. et al. Eur. J. Cancer 62, 138–145 (2016).

    Article  Google Scholar 

  5. Konstorum, A., Vella, A. T., Adler, A. J. & Laubenbacher, R. C. J. R. Soc. Interface 14, 20170150 (2017).

    Article  Google Scholar 

  6. Butner, J. D. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-020-00662-0 (2021).

  7. Trebeschi, S. et al. Ann. Oncol. 30, 998–1004 (2019).

    Article  CAS  Google Scholar 

  8. Butner, J. D. et al. Sci. Adv. 6, eaay6298 (2020).

    Article  CAS  Google Scholar 

  9. Sung, W. et al. Radiother. Oncol. 151, 73–81 (2020).

    Article  CAS  Google Scholar 

  10. Palma, D. A. et al. Lancet 393, 2051–2058 (2019).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Clemens Grassberger

  2. Department of Radiation Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

    Wilfred Ngwa

Authors
  1. Clemens Grassberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wilfred Ngwa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wilfred Ngwa.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grassberger, C., Ngwa, W. Modelling treatment-response rates. Nat Biomed Eng 5, 295–296 (2021). https://doi.org/10.1038/s41551-021-00717-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-021-00717-w

Search

Advanced search

Quick links

Nature Briefing AI and Robotics

Sign up for the Nature Briefing: AI and Robotics newsletter — what matters in AI and robotics research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: AI and Robotics